116 related articles for article (PubMed ID: 32450778)
1. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions.
Pang J; Crawford K; Faraji F; Ramsey C; Kemp A; Califano JA
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):546-553. PubMed ID: 32450778
[TBL] [Abstract][Full Text] [Related]
2. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
[TBL] [Abstract][Full Text] [Related]
3. Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
Ambrosio A; Jeffery DD; Hopkins L; Burke HB
Mil Med; 2019 May; 184(5-6):e400-e407. PubMed ID: 30295883
[TBL] [Abstract][Full Text] [Related]
4. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.
Tom MC; Ross RB; Koyfman SA; Adelstein DJ; Lorenz RR; Burkey BB; Shah C; Suh JH; Bolwell BJ; Savage C; Platz S; Ward MC
J Oncol Pract; 2019 Jun; 15(6):e560-e567. PubMed ID: 31009283
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study.
Adjei Boakye E; Johnston KJ; Moulin TA; Buchanan PM; Hinyard L; Tobo BB; Massa ST; Osazuwa-Peters N
Am J Clin Oncol; 2019 Feb; 42(2):172-178. PubMed ID: 30300170
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
8. The impact of a skilled nursing facility on the cost of surgical treatment of major head and neck tumors.
Seikaly H; Calhoun KH; Stonestreet JS; Rassekh CH; Driscoll BP; Averyt P
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1086-8. PubMed ID: 11556857
[TBL] [Abstract][Full Text] [Related]
9. Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
Eskander A; Krzyzanowska MK; Fischer HD; Liu N; Austin PC; Irish JC; Enepekides DJ; Lee J; Gutierrez E; Lockhart E; Raphael M; Singh S
Oral Oncol; 2018 Aug; 83():107-114. PubMed ID: 30098764
[TBL] [Abstract][Full Text] [Related]
10. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
Genther DJ; Gourin CG
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
[TBL] [Abstract][Full Text] [Related]
11. Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer.
Nocon CC; Kennedy A; Jaffe J; Pruitt J; Kuchta K; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):632-637. PubMed ID: 33983375
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
[No Abstract] [Full Text] [Related]
13. The economic burden of head and neck cancer: a systematic literature review.
Wissinger E; Griebsch I; Lungershausen J; Foster T; Pashos CL
Pharmacoeconomics; 2014 Sep; 32(9):865-82. PubMed ID: 24842794
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population.
Amonkar MM; Chastek B; Samant N; Teitelbaum A
J Med Econ; 2011; 14(4):421-32. PubMed ID: 21619455
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck.
Chang C; Wu SP; Hu K; Li Z; Schreiber D; Oliver J; Givi B
Otolaryngol Head Neck Surg; 2020 Jun; 162(6):881-887. PubMed ID: 32043919
[TBL] [Abstract][Full Text] [Related]
16. End-of-life care pathway of head and neck cancer patients: single-institution experience.
Heinonen T; Loimu V; Saarilahti K; Saarto T; Mäkitie A
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):545-551. PubMed ID: 29247265
[TBL] [Abstract][Full Text] [Related]
17. Economic Burden of Head and Neck Cancer Treatment in North India.
Chauhan AS; Prinja S; Ghoshal S; Verma R
Asian Pac J Cancer Prev; 2019 Feb; 20(2):403-409. PubMed ID: 30803199
[TBL] [Abstract][Full Text] [Related]
18. Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
Gupta A; Sonis ST; Schneider EB; Villa A
Cancer; 2018 Feb; 124(4):760-768. PubMed ID: 29112234
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
Gleich LL; Collins CM; Gartside PS; Gluckman JL; Barrett WL; Wilson KM; Biddinger PW; Redmond KP
Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):26-35. PubMed ID: 12525191
[TBL] [Abstract][Full Text] [Related]
20. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
